Coumarin in Cinnamon: The Hidden Liver Risk Most People Don't Know About

Most people who take cinnamon supplements have no idea they might be consuming a compound that European food safety regulators have formally flagged as a potential liver toxin. The compound is called coumarin. It occurs naturally in common cinnamon — specifically in Cassia varieties — and the amounts present in typical supplement doses can exceed established safety guidelines without anyone being aware of it.

This is not a fringe concern or a theoretical risk invented by overzealous regulators. The European Food Safety Authority (EFSA) has issued formal guidance on coumarin intake limits. Germany's Federal Institute for Risk Assessment (BfR) has specifically warned consumers about high cinnamon consumption. Case reports in peer-reviewed medical literature have documented liver enzyme abnormalities in people taking cinnamon supplements at doses that are readily available in standard capsule products sold globally.

Here is what the science actually says — and what it means for how you choose and use cinnamon.

What Is Coumarin and Where Does It Come From?

Coumarin (2H-chromen-2-one) is a naturally occurring organic compound found in various plants. It gives tonka beans their distinctive vanilla-like scent, appears in lavender and sweet clover, and is present in significant quantities in Cassia cinnamon. It was once used as a synthetic vanilla flavouring in processed foods before studies in the 1950s linked it to liver damage in rodents, leading to a ban on its deliberate use as a food additive in many countries.

The chemistry of coumarin metabolism in humans is fairly well understood. Coumarin is primarily metabolised by the liver enzyme CYP2A6 into 7-hydroxycoumarin, which is then excreted harmlessly. However, a competing metabolic pathway converts coumarin into a reactive epoxide intermediate — a toxic metabolite associated with hepatocellular damage. It is this second pathway that is linked to liver toxicity.

Critically, individual variation in which pathway dominates is substantial. People who are genetically poor metabolisers via the CYP2A6 route — a polymorphism found in approximately 1-3% of European populations and higher proportions in some East Asian populations — process more coumarin through the toxic epoxide pathway. This means some individuals are considerably more vulnerable to coumarin-related liver effects than others. Since there is no standard way for consumers to know their CYP2A6 metaboliser status without genetic testing, safety guidelines are necessarily set to protect the more sensitive portion of the population.

How Much Coumarin Is Actually in Cassia Cinnamon?

Studies measuring coumarin concentrations in Cassia cinnamon consistently find levels that are dramatically higher than in Ceylon. The range cited across the scientific literature is 1mg to 12mg of coumarin per gram of Cassia cinnamon powder or bark, with meaningful variation depending on the specific Cassia variety:

• Chinese Cassia (Cinnamomum cassia): typically 1-6mg per gram
• Vietnamese/Saigon Cinnamon (Cinnamomum loureiroi): typically 6-12mg per gram — the highest coumarin concentrations of any commercially available cinnamon variety
• Indonesian Cassia (Cinnamomum burmanni): typically 1-3mg per gram

Ceylon cinnamon (Cinnamomum verum) contains coumarin at concentrations typically below 0.004mg per gram — less than 1/250th the concentration found in Chinese Cassia, and less than 1/1,500th the concentration found in Vietnamese Cassia. This is not a small difference. It is an almost complete absence of coumarin by comparison.

What the Safety Guidelines Actually Say

The EFSA established a tolerable daily intake (TDI) for coumarin in 2004 at 0.1mg per kilogram of body weight per day. This figure is derived from a no-observed-adverse-effect level (NOAEL) from animal studies, divided by a safety factor of 100 to account for both the difference between animal and human responses and individual human variation.

For an average adult weighing 70 kilograms, this translates to a maximum TDI of 7mg of coumarin per day. Now consider what happens with common cinnamon supplement doses:

• A single 1g capsule made with Chinese Cassia at moderate coumarin content (around 4mg/g) would deliver approximately 4mg of coumarin — already more than half the TDI for a 70kg adult
• A 2g daily dose — used in several blood sugar research studies — could deliver between 4mg and 24mg depending on the Cassia variety used
• At the high end, two 500mg capsules of a Vietnamese Cassia-based product could contain 6-12mg per capsule, totalling 12-24mg per day — between 1.7 and 3.4 times the EFSA's established safe daily intake

Because most supplements simply say "cinnamon" without specifying the species, most consumers have no way of knowing which type they are taking or how much coumarin they are consuming. Someone who has read about cinnamon's potential benefits and starts taking what seems like a reasonable 2g per day may be exceeding safe coumarin thresholds without realising it.

What Does the Research on Liver Effects Show?

Animal studies established the hepatotoxicity concern decades ago. Rats and mice fed high coumarin doses develop liver tumours, and lower sustained doses produce measurable liver enzyme abnormalities. These findings led to coumarin's removal as a deliberate food additive.

In humans, the evidence is less extensive but meaningful. Case reports in the medical literature describe elevated liver enzymes (specifically ALT and AST) in individuals taking cinnamon supplements at commonly recommended doses. In these cases, the liver enzyme elevations normalised after supplementation was stopped — a pattern consistent with reversible hepatotoxicity rather than permanent damage, but nonetheless a genuine adverse effect occurring at doses within the range many supplement users take routinely.

Population modelling from German research groups has estimated that a meaningful proportion of supplement users exceed the EFSA TDI for coumarin from cinnamon supplements alone — not from dietary coumarin from all sources combined, but from cinnamon products specifically. A study published in Molecular Nutrition and Food Research modelled exposure scenarios for German supplement users and found that standard cinnamon supplement use patterns produced coumarin exposures exceeding safety guidelines for a subset of users, particularly those using higher doses or Saigon cinnamon products.

Why This Often Goes Unnoticed

Subclinical liver enzyme elevations are often asymptomatic. The liver has considerable reserve capacity, and mild hepatocellular stress may not produce recognisable symptoms for a long time. Fatigue, nausea, and discomfort in the upper right abdomen can occur, but these are non-specific and easily attributed to other causes. Without routine liver function blood tests — which most healthy supplement users are not having regularly — mild liver enzyme elevations from coumarin accumulation would go undetected.

This is compounded by the fact that people who feel no immediate adverse effects from their cinnamon supplement naturally assume it is safe for continued use. The absence of obvious symptoms is not evidence of the absence of liver effects. The liver's regenerative capacity is considerable, but this should not be taken as licence to exceed coumarin safety guidelines indefinitely.

Ceylon Cinnamon: The Straightforward Solution

From a coumarin standpoint, Ceylon cinnamon occupies a completely different risk category. With coumarin concentrations below 0.004mg/g, even a generous daily dose of 4g of pure Ceylon cinnamon would deliver less than 0.016mg of coumarin — approximately 440 times below the EFSA's TDI for a 70kg adult. At those concentrations, coumarin from Ceylon is nutritionally insignificant.

This is why researchers, dietitians, and clinicians who want to recommend cinnamon supplementation for extended periods increasingly specify Ceylon. The active compounds — cinnamaldehyde, procyanidins, and polyphenols — that drive cinnamon's studied effects on glucose metabolism and insulin sensitivity are present in Ceylon cinnamon. The coumarin issue, however, is essentially absent. There is no meaningful coumarin ceiling when supplementing with Ceylon, which makes it suitable for the research-relevant doses (1-3g per day) used in clinical trials without the accumulation concern that applies to Cassia at those doses.

What to Look For on Labels

The supplement market is poorly regulated for species specificity in cinnamon products. Practical guidance for label reading:

• Reject without hesitation: Labels that say only Cinnamon, Cinnamon Bark, or Cinnamon Bark Extract without naming the species — these are almost certainly Cassia
• Look specifically for: Cinnamomum verum or Cinnamomum zeylanicum — these are the accepted Latin names for Ceylon cinnamon
• Major red flag: Saigon Cinnamon or Vietnamese Cinnamon — C. loureiroi, the highest coumarin variety commercially available
• Positive signal: Companies that explicitly discuss coumarin and explain their use of Ceylon are demonstrating meaningful supply chain transparency

Who Should Be Most Attentive?

While anyone supplementing cinnamon daily benefits from using Ceylon, certain groups face elevated risks from Cassia exposure:

• People with any pre-existing liver condition — any additional hepatotoxic load is of greater concern when liver function is already compromised
• Those taking hepatotoxic medications — including high-dose acetaminophen, certain statins, some antibiotics, and antifungals — since additive hepatotoxic effects are a real concern
• Children and adolescents — lower body weight means a lower absolute coumarin TDI, and adult safety thresholds may not be adequately protective
• Pregnant women — coumarin has been studied for developmental toxicity in animal models; pregnant women should discuss any supplement with their healthcare provider before use
• People of East Asian ancestry — higher prevalences of CYP2A6 poor metaboliser variants in some populations may confer increased coumarin sensitivity

The Clear Takeaway

Coumarin in Cassia cinnamon is a real, documented, and regulatory-acknowledged concern. European safety authorities have established formal limits that standard supplement doses of Cassia-based cinnamon can regularly exceed. Individual metabolic variation means some people are meaningfully more vulnerable than others — and without genetic testing, there is no way to know in advance which category you fall into.

The practical and evidence-consistent solution is to choose Ceylon cinnamon for any regular supplementation. Ceylon contains the same active compounds associated with the studied health benefits of cinnamon, with essentially no coumarin accumulation at even generous daily doses. Zenca Ceylon Cinnamon uses verified Cinnamomum verum formulated in MCT oil softgels for better bioavailability of fat-soluble active compounds — providing a well-tolerated, coumarin-conscious option for those who want to use cinnamon as a consistent part of their daily health routine. If your current cinnamon supplement does not specify Ceylon cinnamon by species name on the label, it is worth taking a closer look before continuing long-term use.